Skip to main content

Table 3 Quantitative values of HBV markers in matched mothers and neonates

From: Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates

Items

 

n

Mother (M)

Neonate (N)

P-value

N/M (Median)

Median (25 %, 75 % IQR)

Median (25 %, 75 % IQR)

HBsAg(+)

FV

87

795.30 (340.28, 2341.25)

1.96 (1.19, 4.56)

0.000

0.002

UC

48

2834.50 (1557.75, 7907.25)

3.84 (2.15, 36.80)

0.000

0.001

HBeAg(+)

FV

136

588.65 (282.33, 790.35)

41.45 (12.90, 128.71)

0.000

0.070

UC

46

1140.50 (579.08, 1536.25)

49.38 (11.83, 317.65)

0.000

0.043

HBV-DNA(+)

FV

18

7.10 (6.88, 8.02)

3.0 (3.0, 3.48)

0.000

0.0001

UC

10

7.59 (6.50, 7.74)

3.84 (3.52, 4.94)

0.004

0.00018

anti-HBe(+)

FV

118

0.029 (0.005, 0.069)

0.012 (0.004, 0.058)

0.073

/

UC

55

0.004 (0.003, 0.010)

0.003 (0.002, 0.010)

0.428

/

anti-HBc(+)

FV

269

0.006 (0.004, 0.080)

0.006 (0.004, 0.072)

0.688

/

UC

112

0.006 (0.005, 0.007)

0.006 (0.005, 0.006)

0.144

/

  1. HBsAg (COI), HBeAg (COI), HBVDNA( log 10copies/mL), anti-HBe (COI), anti-HBc (COI); /:mean titer was not compared between neonates and mothers because the index was measured by competitive binding principle